OUR SERVICES

Regulatory Affairs, Drug Development, Pharmacovigilance, Medical Writing, Pricing & Reimbursement, Market Access

MORE

ABOUT US

Partner of many pharmaceutical companies, managing hundreds of multi-task projects, on a worldwide-scale

MORE

EVENTS

Discover next events

MORE
Nov
01
CPHI 2022 – Frankfurt
MORE
Nov
01
2022
Nov
06
ISPOR Europe 2022
MORE
Nov
06
2022
Nov
14
World Orphan Drug Congress 2022
MORE
Nov
14
2022

BLOG

ALL POSTS
Sep, 28 2022

TRANSPARENCY IN HEALTHCARE: SUNSHINE ACT

The Sunshine Act (Law 62 of May 31st, 2022 published in the Italian Official Journal on June 11th, 2022), concerns the disposition...

READ
Sep, 26 2022

MEDICAL DEVICE CLASSIFICATION – FOCUS ON...

The Regulation (EU) 745/2017 requires stricter classification rules for substance-based medical devices together with timely pharm...

READ
Sep, 20 2022

SOUTH AFRICA: MARKETING AUTHORIZATION REN...

The size of the South Africa’s pharmaceutical market has a value of more than $4 billion (2021 data). A substantial grow of the ...

READ
RPN @regulatorypharmanet - JUN 4

CONTACT US

Our experts are available to help you with any question you might have








 
I accept THE PRIVACY POLICY